Intraosseous Spindle Cell Rhabdomyosarcoma with
MEIS1
NCOA2
Rhabdomyosarcoma
bone
gene fusion
Journal
Cancer investigation
ISSN: 1532-4192
Titre abrégé: Cancer Invest
Pays: England
ID NLM: 8307154
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
1
11
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
ppublish
Résumé
Spindle cell/sclerosing rhabdomyosarcoma (SSRMS) is a clinicopathologically and molecularly heterogeneous disease. Gene fusions have been identified in intraosseous SSRMS, consisting predominantly of
Identifiants
pubmed: 37668330
doi: 10.1080/07357907.2023.2255668
doi:
Substances chimiques
Transcription Factors
0
NCOA2 protein, human
0
Nuclear Receptor Coactivator 2
0
TFCP2 protein, human
0
DNA-Binding Proteins
0
Types de publication
Review
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
704-712Commentaires et corrections
Type : ErratumIn